Showing 1,041 - 1,060 results of 226,904 for search '(( a ((a decrease) OR (we decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.76s Refine Results
  1. 1041
  2. 1042
  3. 1043

    Downregulation of activin A leads to a decrease in proliferation. by Andreia Bufalino (5664958)

    Published 2015
    “…(C) Follistatin at 100 ng/ml significantly blocked BrdU incorporation in SCC-9 ZsGreen LN-1 cells, but no effects on cell cycle distribution were observed (D). Knockdown of activin A significantly decreased proliferation (E), enhancing the number of cells at G0/G1 and reducing the number in the S phase of cell cycle (F). …”
  4. 1044
  5. 1045
  6. 1046

    The <i>TgCRT</i>-deficient parasites displayed a swollen vacuole and a disrupted endolysosomal system. by L. Brock Thornton (6808385)

    Published 2019
    “…TgCPL staining presented as one or more larger and intensely stained puncta, which co-localized with proTgM2AP and TgVP1 (indicated by arrows in the insets). …”
  7. 1047

    Rhodomyrtone decreases expression of inflammatory transcripts by TNF-α+IL-17A stimulated in skin organ cultures. by Julalak Chorachoo (5855852)

    Published 2018
    “…<p>Skin biopsies were pre-treated with 400 ng/ml rhodomyrtone 6 h before stimulation with 10 ng/ml TNF-α and 20 ng/ml IL-17A. Rhodomyrtone treatment decreases production of <i>DEFB4</i>, <i>IL1B</i>, <i>IL17C</i>, <i>IL36G</i>, <i>LCN2</i>, <i>PI3</i>, <i>S100A7</i>, and <i>S100A8</i> transcripts as measured by qRT-PCR at 72 h. …”
  8. 1048
  9. 1049
  10. 1050

    Gramine Derivatives Targeting Ca<sup>2+</sup> Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases by Rocío Lajarín-Cuesta (1530580)

    Published 2016
    “…Hence, we propose this multitarget approach as a new and promising strategy for the treatment of neurodegenerative diseases.…”
  11. 1051
  12. 1052
  13. 1053
  14. 1054
  15. 1055
  16. 1056

    Increased oxidative stress, viral load and decreased survivability of N2a following RIG-I ablation. by Arshed Nazmi (215284)

    Published 2011
    “…No statistically significant change in the viability of N2a post 24 h of JEV-infection was observed. However, RIG-I ablation resulted in significantly decreased viability compared to mock-infected as well as JEV-infected groups (D). …”
  17. 1057
  18. 1058
  19. 1059
  20. 1060